John Merriman

Faculty

John Merriman Headshot

John Merriman

PhD RN AOCNS

Assistant Professor

1 212 998 5375
Accepting PhD students

John Merriman, PhD, RN, AOCNS, is an Assistant Professor at NYU Rory Meyers College of Nursing. His primary research interest is improving cognitive function in postmenopausal women with breast cancer using stress management. He is particularly interested in how multiple determinants of health, including biobehavioral and social determinants, impact the efficacy of stress management interventions in this population.

His recent study was funded by a K99/R00 award from the National Institute of Nursing Research (NR015473). This study aimed to evaluate the feasibility and potential impact of Mindfulness-Based Stress Reduction, contrasting it with a health enhancement program, on cognitive function in postmenopausal women undergoing aromatase inhibitor therapy for breast cancer.

Prof. Merriman is Immediate Past President of the International Society of Nurses in Genetics.

PhD in Nursing, University of California San Francisco
MS in Nursing, University of California San Francisco
BS in Communication, Mississippi College
Chronic disease
Complementary/integrative health
American Nurses Association
Eastern Nursing Research Society
International Society of Nurses in Genetics
Oncology Nursing Society
Sigma Theta Tau International
Postdoctoral Alumni Award, University of Pittsburgh Postdoctoral Association (2016)
International inductee, Sigma Theta Tau (2006)

Symptom Intervention Resources for Cognitive Impairment

Jansen, C., Von Ah, D., Allen, D. H., Mayo, S., Merriman, J., Meyers, J., & Yang, Y. (2025). Oncology Nursing Society.
Abstract
Abstract
Teams of nurse scientists, advanced practice nurses, and staff nurses summarize and synthesize the available evidence regarding symptom interventions. These resources can be used to plan individual patient care, patient education, nursing education, quality improvement, and research.

Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer

Merriman, J., Melnyk, H., Dickson, V. V. V., Bender, C., Yu, G., Djukic, M., & Merriman, J. (2024). In Journal of cancer survivorship : research and practice.
Abstract
Abstract
Few studies have examined aromatase inhibitor therapy relating to role function in breast cancer survivors of working age. Our study sought to identify how pre-therapy sociodemographic and health/treatment-related characteristics, as well as patient-reported symptoms measured every six-months, influence role function during 18 months of AI therapy for early-stage breast cancer.

AMIGO1 upregulation and Notch signaling pathway enrichment following Mindfulness-Based Stress Reduction in postmenopausal breast cancer survivors: Preliminary mechanistic insights from a pilot randomized controlled trial.

Merriman, J., Asam, K., Conley, Y. P., Bender, C. M., Erickson, K. I., Bhagat, T. D., Perez, N., Gormley, M., Mazor, M., Root, J. C., Lindsay, E. K., Carr, K., Washington, A. N., Brown, M., & Aouizerat, B. E.
Abstract
Abstract
~

Longitudinal trajectories of pain and musculoskeletal symptoms during aromatase inhibitor therapy for breast cancer: Demographic, clinical, and genetic predictors

Zhu, Y., Conley, Y. P., Sereika, S. M., Rosenzweig, M. Q., Merriman, J., Gold, M. S., & Bender, C. M.
Abstract
Abstract
~

Whole-transcriptome differential gene expression and functional neural markers of cognitive problems before systemic therapy for breast cancer

Carr, K., Bender, C. M., Conley, Y. P., Aouizerat, B. E., Asam, K., & Merriman, J.
Abstract
Abstract
~

Work-related factors and health-related quality of life in postmenopausal women during aromatase inhibitor therapy for breast cancer

Melnyk, H., Dickson, V. V., Bender, C. M., Djukic, M., & Merriman, J.
Abstract
Abstract
~